Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition, 33000, Bordeaux, France.
Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition, 33000, Bordeaux, France.
Diabetes Metab Syndr. 2023 Oct;17(10):102859. doi: 10.1016/j.dsx.2023.102859. Epub 2023 Sep 27.
Cancer has been proposed as the primary cause of death in type 2 diabetes (T2D). The life expectancy is reduced after a diabetic foot ulcer. We investigated whether Diabetic Foot Disease related to an increased risk of developing a new cancer.
We conducted a retrospective analysis on a cohort of patients hospitalized for T2D between 2009 and 2017, stratified for the risk of diabetic foot ulcer (International Working Group on Diabetic Foot classification). We highlighted new cancers in their medical records until December 2020. The relationship between Diabetic Foot Disease and later cancers was analyzed by multivariable Cox regression and survival curves were compared.
Among 519 patients, 27% had a Diabetic Foot Disease, and 159 were classified as grades 1 or 2 (at risk). As compared to the 218 patients graded 0 according to the IWGDF, they were more men, older, with a longer duration of diabetes, more vascular complications, a greater incidence of insulin use, and a higher skin autofluorescence. During the 54 months of follow-up, 63 (12.1%) new cancers were diagnosed. Baseline Diabetic Foot Disease was significantly associated with a higher risk of cancer (multivariable adjusted Hazard ratio: 2.08, 95%CI: 1.02-4.25), whereas the relation was not significant for subjects at risk of DFU (HR: 1.65, 95%CI:0.81-3.35) CONCLUSION: The risk of cancer was increased twofold in T2D with Diabetic Foot Disease.
癌症已被认为是 2 型糖尿病(T2D)患者的主要致死原因。糖尿病足溃疡会降低患者的预期寿命。我们研究了糖尿病足疾病是否会增加新发癌症的风险。
我们对 2009 年至 2017 年期间因 T2D 住院的患者队列进行了回顾性分析,根据糖尿病足溃疡的风险(国际糖尿病足工作组分类)进行分层。我们在他们的病历中突出显示新的癌症,直到 2020 年 12 月。使用多变量 Cox 回归分析糖尿病足疾病与随后癌症之间的关系,并比较生存曲线。
在 519 名患者中,27%患有糖尿病足疾病,159 名患者被分类为 1 级或 2 级(有风险)。与根据 IWGDF 分级为 0 的 218 名患者相比,他们更多为男性,年龄更大,糖尿病病程更长,血管并发症更多,胰岛素使用率更高,皮肤自发荧光值更高。在 54 个月的随访期间,诊断出 63 例(12.1%)新发癌症。基线糖尿病足疾病与癌症风险显著相关(多变量调整后的危险比:2.08,95%CI:1.02-4.25),而对于有发生 DFU 风险的患者,这种关系不显著(HR:1.65,95%CI:0.81-3.35)。
患有糖尿病足疾病的 T2D 患者患癌症的风险增加了两倍。